article thumbnail

DEA Finally Agrees to Expand Marijuana Research Amid Pressure from Lawsuit

WeedAdvisor

The applications were submitted as far back as 2016. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action. Dozens of Applications”. .

DEA 61
article thumbnail

According To DEA Data Do You Know Which State Grows The Most Illegal Cannabis ?

Cannabis Law Report

You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8 Across the United States, the DEA seized 2.82 million plants in 2017.

DEA 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. More CBD Coverage.

DEA 51
article thumbnail

NORML “Senate Unanimously Approves Legislation Providing US Attorney General with Greater Say in Cannabis Research Decisions”

Cannabis Law Report

In 2016, the Agency announced that it would expand the pool of federally licensed growers beyond just the University of Mississippi (which was initially granted a federal cannabis cultivation license in 1968). Senate members in 2020 passed a similar version of S. 253 in the final weeks of the legislative session. The full text of S.

article thumbnail

What is the Difference Between a Cannabis Recommendation and Cannabis Prescription

United Patients Group

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. For example, if you live in California where Proposition 64 was passed by voters in 2016 legalizing recreational use of marijuana, no recommendation as long as the patient is 21 years of age and older.

DEA 52
article thumbnail

Senators Call For Report On State Of Psychedelic Research

Cannabis Law Report

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). 2] David E.

article thumbnail

Consultancy, SIVA say they have “exclusively” been awarded the federal contract to oversee and direct the rescheduling of cannabis at the federal level

Cannabis Law Report

The following are highlights of this historic agreement: SIVA will exclusively handle the rewrite of the Controlled Substances Act (CSA), with limited involvement allowed from the different federal agencies, including the FDA, DEA, etc. And in 2016 he comes in at 3:22 on this video. Their erstwhile leader is to be found on Linked in.

DEA 60